152 related articles for article (PubMed ID: 21848977)
1. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.
Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA
Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692
[TBL] [Abstract][Full Text] [Related]
3. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.
Cheah AL; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
BMC Infect Dis; 2014 Jun; 14():353. PubMed ID: 24973797
[TBL] [Abstract][Full Text] [Related]
4. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
[TBL] [Abstract][Full Text] [Related]
6. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
7. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
8. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
Poh CH; Oh HM; Tan AL
J Infect; 2006 May; 52(5):383-6. PubMed ID: 16203039
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
Altoparlak U; Koca O; Ozkurt Z; Akcay MN
Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
Worth LJ; Thursky KA; Seymour JF; Slavin MA
Eur J Haematol; 2007 Sep; 79(3):226-33. PubMed ID: 17655696
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
Zaas AK; Song X; Tucker P; Perl TM
Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
17. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
McNeil SA; Malani PN; Chenoweth CE; Fontana RJ; Magee JC; Punch JD; Mackin ML; Kauffman CA
Clin Infect Dis; 2006 Jan; 42(2):195-203. PubMed ID: 16355329
[TBL] [Abstract][Full Text] [Related]
19. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
Chavers LS; Moser SA; Funkhouser E; Benjamin WH; Chavers P; Stamm AM; Waites KB
Microb Drug Resist; 2003; 9 Suppl 1():S69-77. PubMed ID: 14633370
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak.
Beltrami EM; Singer DA; Fish L; Manning K; Young S; Banerjee SN; Baker R; Jarvis WR
Am J Infect Control; 2000 Aug; 28(4):282-5. PubMed ID: 10926704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]